Stephen Willey
Stock Analyst at Stifel
(4.02)
# 560
Out of 5,113 analysts
126
Total ratings
44.57%
Success rate
15.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $22.54 | +77.46% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $111.91 | +2.76% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $2.43 | +352.67% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $78.80 | +58.63% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $68.60 | +88.06% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $101.01 | +13.85% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.65 | +146.91% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $158.44 | -8.48% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.79 | +84.70% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $42.36 | -3.21% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.58 | +164.65% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.88 | +165.96% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $6.81 | +193.90% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $17.68 | +97.96% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $13.45 | +643.49% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.30 | +207.69% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $17.14 | +174.21% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.36 | +1,015.76% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.91 | +109.42% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $41.31 | +50.08% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.23 | +44.46% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.80 | +566.67% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.55 | +18,480.65% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.24 | +837.50% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.47 | +173.04% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $347.97 | -64.65% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $82.21 | -42.83% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $56.27 | +93.71% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.76 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $10.59 | +117.19% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $22.54
Upside: +77.46%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $111.91
Upside: +2.76%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.43
Upside: +352.67%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $78.80
Upside: +58.63%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $68.60
Upside: +88.06%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $101.01
Upside: +13.85%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.65
Upside: +146.91%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $158.44
Upside: -8.48%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.79
Upside: +84.70%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $42.36
Upside: -3.21%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $10.58
Upside: +164.65%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.88
Upside: +165.96%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $6.81
Upside: +193.90%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $17.68
Upside: +97.96%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $13.45
Upside: +643.49%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.30
Upside: +207.69%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $17.14
Upside: +174.21%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.36
Upside: +1,015.76%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.91
Upside: +109.42%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $41.31
Upside: +50.08%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $6.23
Upside: +44.46%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.80
Upside: +566.67%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.55
Upside: +18,480.65%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.24
Upside: +837.50%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.47
Upside: +173.04%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $347.97
Upside: -64.65%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $82.21
Upside: -42.83%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $56.27
Upside: +93.71%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.76
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $10.59
Upside: +117.19%